Tempus AI has signed a three-way deal with AstraZeneca and Pathos AI to construct a data-based oncology model that could ultimately be used to develop new cancer drugs. Tempus will use its “vast ...
Microsoft Corp. said today it’s advancing the local artificial intelligence development capabilities of Windows, as part of an effort to help developers build and experiment and reach new users with ...
Docker Inc., a company that’s best known for its containerized software development tools, is turning its attention to generative artificial intelligence with the launch of a new service called the ...
FDA and EMA have issued 10 guiding principles for AI in drug development with the intended goal of ensuring safety and ...
Funding fuels expansion of the country’s most established developmental therapy model. Series C round led by aMoon Fund, B Capital and Flare Capital Partners with participation from Healthworx, ...
The so-called V-model provides many benefits for organizing the system engineering perspective by depicting the orderly progression, from requirements definition to system-level specification, ...